PRF Technologies PRFX
NASDAQ PRFX
$0.93 -0.03 (-3.23%)
At close: Sep 22, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Cash & Current Investments (2019 - 2026)

PRF Technologies' (PRFX) quarterly Cash & Current Investments came in at $11.5 million in Q2 2026, up 230.14% on a YoY basis from $3.5 million in Q2 2025, and up 178.56% quarter-over-quarter from $4.1 million in Q4 2025.

Analysis

PRF Technologies (PRFX) Cash & Current Investments (2019 - 2026) Analysis & Trends

PRF Technologies (PRFX) has reported Cash & Current Investments for 8 consecutive years, with $11.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash & Current Investments rose 230.14% year-over-year to $11.5 million; the trailing twelve-month figure through Jun 2026 stood at $11.5 million (up 230.14% YoY), and the FY2025 full-year result was $4.1 million, down 2.82% from the prior year.
  • Cash & Current Investments improved to $11.5 million in Q2 2026 per PRFX's latest filing, from $4.1 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $16.6 million in Q1 2022 and bottomed at $2.8 million in Q2 2024.
  • Historically, Cash & Current Investments has averaged $8.2 million across 5 years, with a median of $8.1 million in 2023.
  • The sharpest annual moves came in 2023 and 2026: Cash & Current Investments plunged 55.57% in 2023, then surged 230.14% in 2026.
  • Over 5 years, Cash & Current Investments stood at $10.2 million in 2022, then decreased by 21.17% to $8.0 million in 2023, then plunged by 46.91% to $4.3 million in 2024, then retreated by 2.82% to $4.1 million in 2025, then soared by 178.56% to $11.5 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $11.5 million, $4.1 million, and $3.5 million for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn 3.66 Bn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn 886.50 Mn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn 171.67 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn 127.64 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn 1.84 Bn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn 360.25 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn 142.75 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 290.12 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn 41.25 Mn
10 PRF Technologies 622,054.07 -10.31 Mn - 11.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.54 Mn
Dec 31, 2025 4.14 Mn
Jun 30, 2025 3.49 Mn
Dec 31, 2024 4.26 Mn
Jun 30, 2024 2.79 Mn
Mar 31, 2024 4.32 Mn
Dec 31, 2023 8.03 Mn
Sep 30, 2023 8.58 Mn
Jun 30, 2023 6.16 Mn
Mar 31, 2023 8.15 Mn
Dec 31, 2022 10.18 Mn
Sep 30, 2022 12.98 Mn
Jun 30, 2022 13.87 Mn
Mar 31, 2022 16.57 Mn
Dec 31, 2021 16.54 Mn
Sep 30, 2021 18.34 Mn
Jun 30, 2021 17.80 Mn
Mar 31, 2021 19.44 Mn
Dec 31, 2020 15.68 Mn
Sep 30, 2020 17.72 Mn
API Access

PRF Technologies Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PRFX&period=max&api_key=YOUR_API_KEY